Tag Archives: sean parker

AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results

[Editor’s note: Alex Lash co-authored this report] The American Association for Cancer Research’s annual meeting is wrapping up in Atlanta today. The conference typically focuses on early research and clinical work, not the big trials that can change the way doctors practice medicine and that compete for headline space at conferences like the American Society […]

What Sean Parker Shares with Einstein and the Labradoodle’s Inventor

Sean Parker, Facebook’s first president, just joined a group that’s a favorite topic of history listicles: He’s an innovator who has become abashed by the breakthrough he helped to create. Parker, in an interview with Axios on Wednesday, said Facebook’s founders consciously exploited “a vulnerability in human psychology,” by luring users into an addictive engagement […]

Posted in Boston blog main, Boulder/Denver blog main, Detroit blog main, Indiana blog main, National blog main, National top stories, New York blog main, Raleigh-Durham blog main, San Diego blog main, San Francisco, San Francisco blog main, San Francisco top stories, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged Albert Einstein, Alfred Nobel, Anna Jarvis, Artificial Intelligence (AI), Atomic Bomb, automation, Communications Technology, Dong Nguyen, dynamite, Emoticons, Entrepreneurship, Ethan Zuckerman, facebook, Flappy Bird, Information Age, innovation, Internet, IT, Labradoodle, Mass Media, Orville Wright, Philo Farnsworth, Robert Oppenheimer, Russian Election-Hacking, Scott Fahlman, sean parker, social media, Software, startups, television, Wally Conron, Web | Comments Off

Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More

The 2017 Nobel Prizes with a biomedical bent were announced this week. Three researchers shared the physiology and medicine prize for their work shining light on the circadian rhythms that govern the wake-and-sleep cycles of all organisms. That basic research is working its way into applications such as drugs that help regulate our body clocks. […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Wisconsin blog main, Wisconsin top stories | Tagged Ablynx, Acadia Pharmaceuticals, Amgen, Amicus Therapeutics, ANDA, Anti-Obesity Drugs, Approval, Arbutus Biopharma, Axovant Sciences, Bill & Melinda Gates Foundation, Biohaven, Biotech, BlueBird Bio, C. Diff, cancer immunotherapy, Celgene, ceo, Cerebral Adrenoleukodystrophy, Chemistry, circadian rhythms, CRISPR Therapeutics, cryo-electron microscopy, Cullinan Oncology, CytomX, Deal, deals, Dimension Therapeutics, Donald Trump, electron microscopy, Endocyte, fundraising, Gene Therapy, generic drugs, i-O, Immuno-oncology, initial public offering, IPO, License, Life Sciences, Lorenzo's Oil, M&A, ModeRNA Therapeutics, motif bio, Nobel Prize, opioid crisis, Partnership, Peter Thiel, Pimavanserin, Pompe disease, rare disease, Rhythm Pharmaceuticals, Rodger Novak, Roivant Sciences, Samarth Kulkarni, Scott Gottlieb, sean parker, seres Therapeutics, spinocerebellar ataxia, ulcerative colitis, Ultragenyx Pharmaceutical, Venture Capital, Visterra | Comments Off

Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

It’s a week for the history books. The United Kingdom voted to leave the European Union last night, triggering worldwide financial fears and, perhaps, a breakup of the U.K. itself. Closer to home, Cleveland (pictured) celebrated LeBron James & the Cavaliers’ historic comeback that brought the city its first sports title in over 50 years. […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Detroit blog main, Indiana blog main, National, National blog main, National top stories, New York blog main, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged Abingworth, Affordable Care Act, Annexon Biosciences, Atlas Venture, Biostage, cancer immunotherapy, Caribou Biosciences, Celgene, CRISPR-Cas9, David Charbonneau, deals, Ebola, Eleven Biotherapeutics, Endocyte, Epizyme, FDA, Gene editing, Harvard University, IBM, IFM Therapeutics, Inovio Pharmaceuticals, IPO, Joseph Kim, Life Sciences, Lycera, medicare, Michael Rape, Mike Sherman, Novartis, Nurix, OrthoPediatrics, Paolo Macchiarini, Paratek Pharmaceuticals, Phil Baran, Rachel Haurwitz, Ron Ellis, Roundups, Savara Pharmaceuticals, Scripps Research Institute, sean parker, Selecta Biosciences, Serendex Pharmaceuticals, startups, tazemetostat, University of Pennsylvania, VC, Watson Health, Zika | Comments Off

Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial

[Updated, 6/21/16, 5:40pm. See below.] Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with a landmark clinical trial. Depending on timing, it could be the first to use the gene editing […]

Posted in Boston blog main, National, National blog main, National top stories, New York blog main, New York top stories, San Francisco blog main, San Francisco top stories, Texas blog main, Texas top stories | Tagged Atkins, Biotech, Cannon, Carl June, CRISPR-Cas9, Immunotherapy, Institute, Lainie Ross, Laurie Zoloth, Life Sciences, Mildred Cho, sean parker, The University of Texas MD Anderson Cancer Center, UCSF, University of Pennsylvania | Comments Off

West Coast Biotech Roundup: Theranos, Medivation, Juno, and More

Sean Parker, who made billions of dollars investing in Napster and Facebook, hosted a big party this week with Lady Gaga, John Legend, and a lot of movie stars. Oh, and Parker pledged $250 million to create a cancer immunotherapy center in his own name that will coordinate research between six academic centers spread across […]

Posted in National blog main, National top stories, San Diego blog main, San Diego top stories, San Francisco, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories | Tagged AbbVie, Biotech, cancer, Celgene, deals, Devices, Drugs, Entrepreneurship, Eric Topol, Financing, funding, Genentech Roche, Immunotherapy Foundation, innovation, Innovation Economy, Juno Therapeutics, KaloBios, Life Sciences, Medivation, Molecular Stethoscope, Nancy Hong, Niall O'Donnell, Orbimed Advisers, Parker Institute for Cancer Immunotherapy, people, Ralph Whitworth, Rivervest Venture Partners, sean parker, Silverback Therapeutics, startups, Stephen Quake, Stephen Thompson, WuXi AppTec, Zavante Therapeutics | Comments Off

LinkedIn: The Missing Manual Worth Reading

I picked up The Start-up of You, the new book published this week by LinkedIn founder Reid Hoffman and journalist-entrepreneur Ben Casnocha, with some trepidation. I feared that the title was intended literally—that this would be one of those dreary business books that spends seven chapters twisting reality to fit its gimmicky metaphor. (I’ve got […]

Posted in Boston blog main, Boston top stories, Detroit blog main, Detroit top stories, National, National blog main, National top stories, New York blog main, New York top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories | Tagged Ben Casnocha, books, LinkedIn, Mark Zuckerberg, PayPal, PayPal Mafia, Peter Thiel, Reid Hoffman, sean parker, Social Networking, The Start-Up of You, wwwade | 11 Comments

Terry Cross: Michigan Needs to Break Down Its Proverbial Silos

It’s Oscar weekend folks! Come Sunday, we’ll know if a stammering King outshines a boozy U.S. Marshal or whether a crazy ballerina edges out a lesbian mother. God, I love the movies! But one actor won’t be taking home any hardware because…well, he wasn’t nominated. And that’s a damn shame because he was really good, […]

Posted in Detroit, Detroit blog main, Detroit top stories, National blog main | Tagged Entrepreneurship, facebook, innovation, Mark Zuckerberg, sean parker, Silicon Valley, social networks, Software, startups, Terry Cross | 2 Comments

$9M for Causes

Causes, the Berkeley, CA-based philanthropy startup co-founded by former Facebook executive Sean Parker, said this week that it has raised $9 million in new funding. The mezzanine round was led by Menlo Park’s New Enterprise Associates and included angel and super-angel investors Marc Benioff, Ron Conway, Karl Jacob, Dustin Moskovitz, Keith Rabois, and Founders Fund. […]

Posted in National briefs, San Francisco, San Francisco briefs | Tagged Causes, deals, Dustin Moskovitz, facebook, Founders Fund, IT, Karl Jacob, Keith Rabois, Marc Benioff, NEA, New Enterprise Associates, Ron Conway, sean parker, VC | Comments Off

Twitter Plea Helps Baydin Get Seed Money from Angel Investor Dave McClure; Startup Moving to the Valley Next Month

So an entrepreneur helps out a prominent angel investor when the latter needs a ride, and gets a seed investment as a result. It sounds like something you might see in a movie. But it’s a reality for Baydin, an e-mail technology startup out of Boston (but soon to be based in the San Francisco […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, San Francisco blog main | Tagged 500 Startups, Accelerator, Angel Investors, Boomerang, Dave McClure, deals, e-mail, Entrepreneurship, facebook, Financing, Founders Fund, funding, Gmail, innovation, Internet, Mark Zuckerberg, Mint.com, sean parker, Simply Hired, SlideShare, startups, TaskRabbit, TechStars, Techstars Boston, thredUP, Twitter, Web, Zendesk | 7 Comments

Tag Archives: sean parker

Archives

Meta